Company Overview
Verso Biosense R&D Limited is listed at the official companies registry as Active Private Limited Company. The company was incorporated on Thursday 26 November 2015, so this is a well established company. Verso Biosense R&D Limited has been in business for 10 years and 4 months. The accounts status is total exemption full and the accounts are next due on Wednesday 30 September 2026.
Registered Address

Milton Park, Milton, Abingdon, Oxfordshire, OX14 4RZ
Credit Reports Available

These credit rating reports are available now:


Credit Analysts Report
Get Report >>

Standard Credit Report
Get Report >>

Basic Credit Report
Get Report >>

24/7 credit rating data feed - no UK company credit reports are updated faster

Companies House Data
Company NameVERSO BIOSENSE R&D LIMITED
Company Number09890252
Registered Office AddressMilton Park
 Milton
 OX14 4RZ
Company CategoryPrivate Limited Company
Company StatusActive
Country of OriginUnited Kingdom
Incorporation Date26/11/2015
Accounting Reference Date Day31
Accounting Reference Date Month12
Accounts Next Due Date30/09/2026
Accounts Last Made Up Date31/12/2024
Accounts Account CategoryTOTAL EXEMPTION FULL
Returns Next Due Date24/12/2016
Previous Company NameChanged Date
VIVOPLEX ANIMAL HEALTH LIMITED01 May 2023
VIVOPLEX INDUSTRIAL LIMITED17 May 2019
VIVOPLEX LIMITED06 Oct 2017
Directors & Members
Show Resigned
Charles Dickson - Director
(British, 44 years old, born February 1982)
Appointed 26 November 2015
 Active
Christopher Dickson - Director
(British, 67 years old, born September 1959)
Appointed 26 November 2015
 Active
Helen Dickson - Director
(British, 43 years old, born September 1983)
Appointed 28 November 2017
 Active
James Dickson - Director
(British, 43 years old, born September 1983)
Appointed 28 November 2017
 Active
Kathryn Rowley - Director
(British, 54 years old, born June 1972)
Appointed 19 May 2025
 Active
Secretaries
No Secretaries Appointed
Other Company Directorships
Charles Dickson
AMBIT BOVIS LIMITED
APACHE 2009 LLP
APACHE CAPITAL PARTNERS LIMITED
ASSURA SERVICES LIMITED
BLEASDALE MOOR AND ESTATE LIMITED
CROFTLANE LIMITED
PETER ALAN DICKSON FOUNDATION
SAINT ALI LTD
TARNCOURT (MALDON) LTD
TARNCOURT (WELLINGBOROUGH) LTD
TARNCOURT CAPITAL LIMITED
TARNCOURT DEVELOPMENTS LLP
TARNCOURT GROUP HOLDINGS LLP
TARNCOURT INDUSTRIAL PROPERTIES LLP
TARNCOURT INVESTMENTS LLP
TARNCOURT PROPERTIES LIMITED
TENTH AVENUE (DEESIDE) LIMITED
VERSO BIOSENSE LIMITED
WORKSHOP INVESTMENTS LIMITED
WORKSHOP TRADING (LONDON) LIMITED
WORKSHOP TRADING HOLDINGS LIMITED
Christopher Dickson
ASCRIBE GROUP LIMITED
ASCRIBE HOLDINGS LIMITED
ASCRIBE LIMITED
FIDELITY DATA NETWORKS LIMITED
FIDELITY HEALTHCARE TECHNOLOGIES LIMITED
HYBRID 4 LIMITED
RIVERSIDE COURT, BATH (MANAGEMENT COMPANY) LIMITED
SCROLL BIDCO LIMITED
VERSO BIOSENSE GROUP LIMITED
VERSO BIOSENSE LIMITED
Helen Dickson
TARNCOURT GROUP HOLDINGS LLP
VERSO BIOSENSE GROUP LIMITED
James Dickson
AMBIT BOVIS LIMITED
ASSURA SERVICES LIMITED
BARKBY HOSPITALITY LIMITED
BARKBY LEISURE LIMITED
BLEASDALE MOOR AND ESTATE LIMITED
CROFTLANE LIMITED
MARE STREET KITCHEN TRADING LIMITED
PETER ALAN DICKSON FOUNDATION
TARNCOURT (MALDON) LTD
TARNCOURT (WELLINGBOROUGH) LTD
TARNCOURT AMBIT LIMITED
TARNCOURT AMBIT PROPERTIES LIMITED
TARNCOURT GROUP HOLDINGS LLP
TARNCOURT INDUSTRIAL PROPERTIES LLP
TARNCOURT INVESTMENTS LLP
TARNCOURT PROPERTIES LIMITED
VERSO BIOSENSE GROUP LIMITED
WORKSHOP INVESTMENTS LIMITED
WORKSHOP TRADING (LONDON) LIMITED
WORKSHOP TRADING HOLDINGS LIMITED
Kathryn Rowley
CELLESCE LIMITED
LYMPHA MOTUS LIMITED
SYMMETRIST LTD
VERSO BIOSENSE GROUP LIMITED
VERSO BIOSENSE LIMITED
Balance Sheet Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Balance Sheet
Fixed Assets 0 0 0
Current Assets 10 10 10
Creditors Due Within One Year 8,972 8,972 8,972
Working Cap -8,962 -8,962 -8,962
Total Assets Less Current Liabilities -8,962 -8,962 -8,962
Long-term Liabilities 0 0 0
Net Assets -8,962 -8,962 -8,962
Share Capital & Reserves
Share Cap - - -
Profit & Loss Reserves - - -
Other Reserves - - -
Shareholders Funds -8,962 -8,962 -8,962
Common Size Financial Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Tangible Fixed Assets - - -
Fixed Assets 0.0% 0.0% 0.0%
Stocks Inventory - - -
Debtors 100.0% 100.0% 100.0%
Cash Bank In Hand - - -
Current Assets 100.0% 100.0% 100.0%
Creditors Due Within One Year 89720.0% 89720.0% 89720.0%
Net Current Assets Liabilities -89620.0% -89620.0% -89620.0%
Creditors Due After One Year - - -
Accruals Deferred Income - - -
Provisions For Liabilities Charges - - -
Net Assets Liabilities Including Pension Asset Liability - - -
Called Up Share Capital - - -
Share Capital Allotted Called Up Paid - - -
Profit Loss Account Reserve - - -
Shareholder Funds -89620.0% -89620.0% -89620.0%
Capital Employed - - -
Total Assets Less Current Liabilities -89620.0% -89620.0% -89620.0%
Financial Ratio Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Liquidity Ratio 0.0 0.0 0.0
Solvency Ratio 0.0 0.0 0.0
Reserves to Assets - - -
Secured Creditors Unlock full report
Mortgages Charges 0
Mortgages Outstanding 0
Mortgages Part Satisfied 0
Mortgages Satisfied 0
Assets and Debt Analysis Unlock full report
Accounts Date 31-Dec-2024 31-Dec-2022 31-Dec-2021
Assets 10 10 10
Debt 8,972 8,972 8,972
Net Assets/Debt -8,962 -8,962 -8,962
It is not clear that the company was actively trading prior to the latest financial data filed. Examination of the full accounts may provide further information. If the company remains active on the company register it may have traded in the period since the date of the latest filed accounts. A full credit report may provide information relating to trade payment history and county court or court judgments if any.
Public Record Information Unlock full report
Exact Court Judgements
Period of Months Last 12m 13-24m 25-36m 37-48m 49-60m 61-72m
Number of Exact CCJS X Y Y X X Y
Value of Exact CCJS YXY YK S S X KX
Supplier Credit Limits Unlock full report
Date Sector Notified Amount Terms
XK-SXY XKXYXK SXSKXYXK £X,000 XS XYSKS
SK-SYY SKXYXKYKKY KSXX KKXXYXS £YY,000 YS XYSKS SK YXXSXS
YK-SXY XKXYXYYK SXSXYXK £SX,000 XS XYSKS
Payment Records Unlock full report
Payment Records from it's suppliers' company ledger show how a company is paying its suppliers

Payment Analysis

Total Invoices Paid Before
30 days due		 Paid After
30 days due		 Owing Before
30 days due		 Owing after
30 days due
XYX SX K YX X
Company Valuation Analysis Unlock full report

Going Concern Valuation

The going concern valuations value the company on the basis that it continues to trade without the threat of liquidation for the foreseeable future. These valuations are primarily profit and cashflow based.

Valuations Valuation Measures
Estimated High Value £XSI,000 Retained Profit £YX,000
Estimated Mid Value £YY,000 EBIT £SY,000
Estimated Low Value £X,000 EBITDA £SSX,000

Liquidation Valuation

The liquidaton valuation values the company as if it were to cease trading and assets were subject to rapid disposal to cover liabilities. This valuation is primarily asset based.

Valuations Valuation Measures
Estimated High Value £XY,000 Total Assets £XIX,000
Estimated Mid Value £Y,000 Net Assets £YX,000
Estimated Low Value £S,000 Tangible Equity £SX,000

The above valuations are based on our own algorithms and take no account of many factors that can influence actual valuations realized and should not therefore be assumed to be accurate.
Credit Status Checklist Unlock full report
Business Growth Please purchase a report to see true comments
EBITDA Purchase a report to see true comments
Dividends Please purchase a report to see true comments about this company
Retained Profits Retained Profits for this company
Debt Interest Debt Interest for this company
Cash Flow Cash Flow for this company
CCJs CCJs for this company
Age of Company Age of Company for this company
Solvency Solvency for this company
Secured Creditors Secured Creditors for this company
Ownership Ownership for this company


First Report Score: (0-10) X
Financial Status Guide:
10 Very Strong
9 Strong
8 Very Good
7 Good
6 Above Average
5 Average
4 Below Average
3 Poor
2 Weak
1 Very Weak
0 Critical

Risk Score Trend

Risk Rating Unlock full report

This is the credit risk assessment used by one of the top UK credit reference agencies.

Risk Score (1-100) X
Risk Band Description XXMXMXMX SISX
Risk Assessment Meeting of Creditors
Credit Rating XSKX
Altman Z Score Credit Risk Rating Unlock full report

There have been many bankruptcy predictors developed, however none has been so thoroughly tested and broadly accepted as the Altman Z-Score.

Z Score X
Risk Band XY
Risk Band Description The Z Score is not used for small companies where full accounts are not filed because profit and loss account items are required to calculate the score.

Z Score Bands

1 Low Risk 3.00 and above
2 Caution 2.63 - 2.99
3 Risk of Failure within 2 years 1.24 - 2.62
4 High Probability Failure Below 1.24
Other Business around OX14 4RZ
OXFORD IMMUNOTEC GLOBAL LIMITED
143 PARK DRIVE, MILTON, ABINGDON, OX14 4RZ
EVOTEC (UK) LIMITED
114 INNOVATION DRIVE, MILTON PARK, MILTON, ABINGDON, OXFORDSHIRE, OX14 4RZ
FRESHNET SYSTEMS LIMITED
UNIT 1, 115 MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RZ
SEMPER EADEM LIMITED
C/O Zonal 115a Innovation Drive, Milton Park, Abingdon, OX14 4RZ
APTUIT (RICLIV) LIMITED
Unit 111 Milton Park, Oxford, Oxfordshire, OX14 4RZ
APTUIT (OXFORD) LIMITED
111 INNOVATION DRIVE, MILTON PARK, ABINGDON, OXFORDSHIRE, OX14 4RZ
HIGH LEVEL SOFTWARE LTD
UNIT 1 115 INNOVATION DRIVE, MILTON PARK, MILTON, ABINGDON, OX14 4RZ
OXFORD DIAGNOSTIC LABORATORIES (UK) LIMITED
143 PARK DRIVE, MILTON, ABINGDON, OX14 4RZ
CYPROTEX RESEARCH LIMITED
114 Innovation Drive, Milton Park, Milton, Abingdon, Oxfordshire, OX14 4RZ
OXFORD BIOTHERAPEUTICS LTD
SUITE A, SECOND FLOOR, THE SCHRODINGER BUILDING HEATLEY ROAD, OXFORD SCIENCE PARK, OXFORD, OX14 4RZ
Document Filings
Confirmation statement made on 25 November 2025 with no updates
Termination of appointment of Hywel Morgan as a director on 11 June 2024
Termination of appointment of Nicholas Stephen Macklon as a director on 25 November 2025
Change of details for Verso Biosense Group Limited as a person with significant control on 29 August 2017
Appointment of Mrs Kathryn Victoria Rowley as a director on 19 May 2025
Termination of appointment of Joseph John Cefai as a director on 31 December 2024
Confirmation statement made on 25 November 2024 with no updates
Termination of appointment of Alexander Charles Wallace Snow as a director on 11 June 2024
Change of details for Vivoplex Medical Limited as a person with significant control on 22 February 2021
Appointment of Professor Nicholas Stephen Macklon as a director on 11 June 2024
Appointment of Prof Hywel Morgan as a director on 11 June 2024
Confirmation statement made on 25 November 2023 with no updates
Termination of appointment of Davina Margaret Dickson as a director on 3 April 2023
Appointment of Dr Joseph John Cefai as a director on 3 April 2023
Termination of appointment of Hywel Morgan as a director on 3 April 2023
Certificate of change of name
Confirmation statement made on 25 November 2022 with no updates
Director's details changed for Mr James Duncan Dickson on 14 November 2022
Confirmation statement made on 25 November 2021 with no updates
Confirmation statement made on 25 November 2020 with no updates
Terms and Conditions Cancellations Contact Us

In using this service you agree to the Terms and Conditions

© 2026 Check Free